Understanding osteoporosis
Osteoporosis is a disease of compromised bone strength — the product of both how much bone you have and how well it is built. Here is what that means, how bone is constantly remodeled, and how the disease develops silently over decades.
Key takeaways
- Osteoporosis is defined by reduced bone strength and increased fracture risk — not only by a low bone-density score.
- Bone mineral density explains roughly 60–70% of bone strength; microarchitecture and bone quality account for the rest.
- Bone is living tissue, continuously remodeled — in osteoporosis, resorption outpaces formation.
- The disease is silent until a fracture, and fracture risk can stay elevated for 20–30 years after menopause.
What is osteoporosis?
Osteoporosis is a chronic, progressive skeletal disease in which bone becomes fragile and prone to fracture. The word means "porous bone." Its defining feature is compromised bone strength, which reflects two things at once: bone mass (how much mineral is present, measured as bone mineral density, or BMD) and bone quality (the internal architecture, the turnover rate, mineralization, and accumulated micro-damage).
Clinically, osteoporosis is often defined by a bone-density T-score of −2.5 or lower at the hip or spine on a DXA scan — meaning bone density 2.5 standard deviations below that of a healthy young adult. But that threshold is a convenience, not the whole disease. A person can fracture from fragility with a T-score above −2.5, and the presence of a fragility fracture is itself enough to diagnose osteoporosis and place a patient at very high risk, independent of the number on the scan.
What this means for you
Think of osteoporosis less as "a number is low" and more as "my bones may break under loads they should tolerate." That reframing matters, because it explains why two people with the same T-score can have very different fracture risk — and why the goal of care is preventing fractures, not chasing a number.
Osteoporosis is common. In the United States, roughly 2 million fractures a year are attributed to it, and by 2030 more than 13 million Americans over 50 are projected to have it. About 1 in 2 women and up to 1 in 4 men over the age of 50 will break a bone because of osteoporosis in their lifetime. More fractures occur each year from osteoporosis than heart attacks, strokes, and breast and prostate cancers combined.
Osteoporosis-related fractures each year in the US.
Women over 50 will have an osteoporotic fracture in their lifetime (up to 1 in 4 men).
Of bone strength is explained by density; the rest is quality and architecture.
Bone remodeling and what makes bone strong
Bone is not inert scaffolding. It is living tissue that is continuously torn down and rebuilt in a process called remodeling. Most of the adult skeleton is renewed this way over the course of years. Remodeling lets bone repair micro-damage, adapt to load, and release or store minerals — but it depends on a balance between two opposing cell teams.
- Osteoclasts resorb (remove) old or damaged bone.
- Osteoblasts form new bone to replace it.
- Osteocytes — cells buried in the bone matrix — sense strain and orchestrate the whole cycle.
A remodeling cycle moves through activation (osteoclasts are recruited), resorption, reversal, formation (osteoblasts lay down new bone), and quiescence (the surface rests). When resorption and formation are balanced, bone mass is preserved. The biological hallmark of osteoporosis is an imbalance: resorption outpaces formation, so a little more bone is removed than replaced with each cycle. Repeated over years, this thins the bone and erodes its internal lattice.
Several features make bone strong, and BMD captures only some of them:
- Mineral and collagen content — the composite that gives bone both stiffness and toughness.
- Size and shape — a wider bone resists bending better.
- Microarchitecture — the trabecular lattice and cortical thickness (this is what "bone quality" largely refers to).
- Accumulated damage — micro-cracks that remodeling normally repairs.
Because BMD accounts for only 60–70% of strength, "normal" density does not guarantee strong bone. Two women of the same age with identical BMD can have very different microarchitecture — and the one with the degraded lattice is the one who fractures. This is why tools that look beyond density, such as the trabecular bone score, add real information (see Beyond BMD).
For cliniciansCoupling, the remodeling space, and why anabolics differ
Antiresorptives act primarily by suppressing osteoclast-mediated resorption; the transient BMD gain they produce is largely from filling the remodeling space and completing secondary mineralization, with modest true tissue gain. Osteoanabolic agents (PTH/PTHrP analogs, and the anti-sclerostin antibody with its dual formation-stimulating, resorption-inhibiting action) increase modeling-based and remodeling-based formation, producing larger and faster gains — particularly at trabecular sites and, for the dual-action agent, at the hip. This mechanistic difference is the biological basis for the anabolic-first sequencing discussed under Treatment.
Natural history: how osteoporosis develops
Bone mass rises through childhood and adolescence, peaks in the late 20s (peak bone mass), and then slowly declines. The single largest accelerant in women is menopause: with the loss of estrogen, bone loss speeds up dramatically — one classic study estimated women lose bone roughly 6× faster in the years around menopause than in the 25 years before it. In men, testosterone and estrogen decline more gradually, and fragility fractures climb about a decade later than in women.
Because the average woman reaches menopause around 51, sustains a first fragility fracture around her late 50s, and may live into her 80s, osteoporosis is a condition that must be managed across 20–30 years. It is not treated with a single prescription and forgotten; it is managed in sequences, with reassessment over time (see goal-directed treatment).
Crucially, all of this happens silently. There is no ache that signals thinning bone. The first sign is often a broken bone — a wrist after a stumble, a spine fracture from bending or lifting, or a hip after a minor fall. That is why screening and risk assessment matter so much: the window to prevent the first fracture is before it happens. Continue to Risk & Fractures and Diagnosis.
Questions about your bone health?
Board-certified endocrinologists. Physician-scientists. Straight answers about what builds bone and what does not.